HomeAbout SNHPAMembership InformationCorporate PartnersMembers OnlyEvents340B ResourcesAdvocacyCareers/Rx Job SolutionsLinksNews
Welcome, Guest!
Member
Login:
Forgot your
password?
Home
About SNHPA
Membership Information
Corporate Partners
Members Only
Events
340B Resources
Advocacy
Rx Job Solutions
Links
News
Search SNHPA

Home > What's New > Lawmakers Urge HRSA To Withdraw Proposed Patient Definition Guidelines
Lawmakers Urge HRSA To Withdraw Proposed Patient Definition Guidelines

Eighteen members of the U.S. House of Representatives and 16 members of the U.S. Senate signed letters to the new head of the Health Resources and Services Administration, requesting that she withdraw a Bush Administration proposal to limit the definition of a patient under the 340B drug discount program.

The letter to Administrator Mary Wakefield, drafted by Reps. Bobby Rush (D-Ill.) and Jo Ann Emerson (R-Mo.), warned that implementation of the proposed guidance would prevent safety-net providers from offering care to the indigent populations that the 340B program was created to support.

The Senate letter authored by Senators Bill Nelson (D-Fla.) and John Thune (R-S.D.) asked HRSA to to revise and reissue a 340B patient definition guidance that will preserve the program's integrity without limiting its reach.
 
Federal Drug Discount and Compliance Monitor Learn more about The Monitor, a monthly publication covering the latest news in the 340B program and other federal drug discount programs.
Untitled Document

PLATINUM CORPORATE PARTNERS
American Health Care

Cardinal Health
AmerisourceBergen Drug Company

AmerisourceBergen Solutions Group

Pharmacy Healthcare Solutions
eRx Network

McKesson

NEChealth Network
PDX-NHIN-Rx.com

Sentry Data Systems
Talyst

Wellpartner, Inc.

GOLD CORPORATE PARTNERS

Comprehensive Pharmacy Services EXPRESS SCRIPTS SUNRx

SILVER CORPORATE PARTNERS

ESI

NON-PROFIT AFFILIATES




1501 M Street NW 7th Floor Washington, DC 20005 Phone: 202-552-5850 Fax: 202-552-5868

© Copyright 2010 Safety Net Hospitals for Pharmaceutical Access